NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. Pennsylvania. NH resident? GA resident?

Legislation 126

Legislation Clinical Trials Research and Development Access 126

Project CBD

FEBRUARY 28, 2023

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 21, 2022

The comprehensive legislation would end federal cannabis prohibition by removing cannabis from the Controlled Substances Act; empower states to create their own cannabis laws; ensure federal regulation protects public health and safety; and prioritize restorative and economic justice .

Safety 52

Safety Legislation Clinical Trials Banking 52

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Senior Policy Advisor, Diversion Control Division. Amidst growing evidence that marijuana can be used to effectively treat post-traumatic stress disorder , this bill from California Democrat Barbara Lee focuses on greatly expanding access to medical marijuana for veterans. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. for the production of cannabis used in federally-regulated clinical trials. Research quality” cannabis sparked earlier controversy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Trial of Psilocybin Versus Escitalopram for Depression , 384 NEW ENG.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision. Clinical Trials and Human Subject Protections. Here are the top five considerations: 1.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States , and a lack of safety for the use of the drug under medical supervision. federal law.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. states there are dispensaries where most people have access to cannabis drugs. You really can’t kill people with cannabis.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Cannabis Law Report

MAY 1, 2022

The Psychedelic Bar Association (PBA) is an association of attorneys and legal professionals dedicated to solving the novel legal and policy issues impacting the emerging psychedelics sector. The PBA Religious Use Committee provides expertise around the intersections of law, policy, psychedelics, and religion.

Safety 52

Safety History Programs Clinical Trials 52

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). That access would be available under the auspices of having a chronic, untreatable mood disorder.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

MARCH 8, 2021

1455 covers three major themes: medical marijuana advertising, THC potency/access to high-THC products, and administrative issues. Authorizing the department to sample marijuana delivery devices from a dispensing facility to determine safety [p. Food & Drug Association’s role in H.B. What is Florida House Bill 1455?

THC 116

THC Research and Development Treatment Patients 116

The Joint Blog

OCTOBER 21, 2020

Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. Although scientific research on this has a long way to go, previous studies and clinical trials have produced promising results.

CBD 36

CBD Legalization Oil Hemp 36

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Sesen Bio remains committed to the health and safety of patients, caregivers and employees.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The campaign is designed to remind citizens that while cannabis use is now legal, operating vehicles while under its influence remains against the law and is a public safety issue.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

JULY 15, 2022

They then go off to their separate sections, which are again all controlled by biometric fingerprint scanning for access,” Mr Benjamin said. Workers will have their fingerprints scanned before being allowed to access the turnstile to the Medifarm facility. ( “They get changed. ABC Rural: Jennifer Nichols ).

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. Sonya Yruel/Drug Policy Alliance). Kevin McGovern/Shutterstock). What’s in your CBD?

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. Andrew Yang.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Many of these are meant to address public safety risks, especially for young people. For non-US citizens, Malyshev explains, this can result in a lifetime ban from entry into the US under current policy. alcoholic beverages, caffeine, and tobacco). 2% THC—the United Nations has said it will revisit cannabis under the Single Convention.

Law 40

Law Seed-To-Sale Hemp Recreational 40